Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Atovaquone |
Trade Name | Mepron |
Synonyms | |
Drug Descriptions |
Mepron (atovaquone) is an anti-malarial drug typically used to treat pneumocystis pneumonia and toxoplasmosis, however, may also have an effect on cancer stem cells via the Warburg effect, potentially resulting in decreased cell proliferation and apoptosis (PMID: 27136895). |
DrugClasses | |
CAS Registry Number | 95233-18-4 |
NCIT ID | C28838 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atovaquone | Atovaquone | 0 | 3 |
Atovaquone + Cytarabine + Daunorubicin + Etoposide | Atovaquone Cytarabine Daunorubicin Etoposide | 0 | 1 |
Atovaquone + Cytarabine + Daunorubicin + Gemtuzumab ozogamicin | Atovaquone Cytarabine Daunorubicin Gemtuzumab ozogamicin | 0 | 1 |